Plasma concentrations of VEGF and bFGF in patients with gastric carcinoma - PubMed (original) (raw)
Plasma concentrations of VEGF and bFGF in patients with gastric carcinoma
T Yoshikawa et al. Cancer Lett. 2000.
Abstract
We examined plasma levels of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) in 54 patients with gastric carcinoma. Postoperative survival was significantly poorer in patients with plasma VEGF levels more than 10.0 pg/ml at the time of surgery. By an univariate analysis of the factors affecting survival, serosal invasion, lymph node metastasis, peritoneal dissemination, lymphatic vessel invasion, curability, and VEGF proteins were significant. By a multivariate analysis only VEGF levels and curability remained significant. Patients with recurrent disease, including liver metastasis, had significantly higher plasma VEGF concentrations than those with resectable primary tumors. VEGF, not bFGF, may serve as an independent prognosticator and a sensitive indicator for liver recurrence in patients with gastric carcinoma.
Similar articles
- Prognostic significance of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin in patients with resectable hepatocellular carcinoma after surgery.
Chao Y, Li CP, Chau GY, Chen CP, King KL, Lui WY, Yen SH, Chang FY, Chan WK, Lee SD. Chao Y, et al. Ann Surg Oncol. 2003 May;10(4):355-62. doi: 10.1245/aso.2003.10.002. Ann Surg Oncol. 2003. PMID: 12734082 - Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?
Dosquet C, Coudert MC, Lepage E, Cabane J, Richard F. Dosquet C, et al. Clin Cancer Res. 1997 Dec;3(12 Pt 1):2451-8. Clin Cancer Res. 1997. PMID: 9815646 - Elevated preoperative serum levels of angiogenic cytokines correlate to larger primary tumours and poorer survival in non-small cell lung cancer patients.
Brattström D, Bergqvist M, Hesselius P, Larsson A, Lamberg K, Wernlund J, Brodin O, Wagenius G. Brattström D, et al. Lung Cancer. 2002 Jul;37(1):57-63. doi: 10.1016/s0169-5002(02)00027-2. Lung Cancer. 2002. PMID: 12057868 - Vascular endothelial growth factor and basic fibroblast growth factor in patients with squamous cell oesophageal cancer.
Wallner G, Ciechański A, Dabrowski A, Kozłowski M, Roliński J, Laudański J, Cwik G. Wallner G, et al. Folia Histochem Cytobiol. 2001;39 Suppl 2:122-3. Folia Histochem Cytobiol. 2001. PMID: 11820569 - Circulating angiogenesis regulators in cancer patients.
Kuroi K, Toi M. Kuroi K, et al. Int J Biol Markers. 2001 Jan-Mar;16(1):5-26. doi: 10.1177/172460080101600102. Int J Biol Markers. 2001. PMID: 11288955 Review.
Cited by
- Role of Basic Fibroblast Growth Factor in Cancer: Biological Activity, Targeted Therapies, and Prognostic Value.
Ardizzone A, Bova V, Casili G, Repici A, Lanza M, Giuffrida R, Colarossi C, Mare M, Cuzzocrea S, Esposito E, Paterniti I. Ardizzone A, et al. Cells. 2023 Mar 24;12(7):1002. doi: 10.3390/cells12071002. Cells. 2023. PMID: 37048074 Free PMC article. Review. - Current and emerging anti-angiogenic therapies in gastrointestinal and hepatobiliary cancers.
Saoudi González N, Castet F, Élez E, Macarulla T, Tabernero J. Saoudi González N, et al. Front Oncol. 2022 Oct 10;12:1021772. doi: 10.3389/fonc.2022.1021772. eCollection 2022. Front Oncol. 2022. PMID: 36300092 Free PMC article. Review. - Angiogenesis-related non-coding RNAs and gastrointestinal cancer.
Razavi ZS, Asgarpour K, Mahjoubin-Tehran M, Rasouli S, Khan H, Shahrzad MK, Hamblin MR, Mirzaei H. Razavi ZS, et al. Mol Ther Oncolytics. 2021 May 15;21:220-241. doi: 10.1016/j.omto.2021.04.002. eCollection 2021 Jun 25. Mol Ther Oncolytics. 2021. PMID: 34095461 Free PMC article. Review. - The crucial role of blood VEGF kinetics in patients with locally advanced esophageal squamous cell carcinoma receiving curative concurrent chemoradiotherapy.
Chen YH, Lu HI, Lo CM, Wang YM, Chou SY, Hsiao CC, Huang CC, Shih LH, Chen SW, Li SH. Chen YH, et al. BMC Cancer. 2018 Aug 20;18(1):837. doi: 10.1186/s12885-018-4731-9. BMC Cancer. 2018. PMID: 30126380 Free PMC article. - A CD44-specific peptide, RP-1, exhibits capacities of assisting diagnosis and predicting prognosis of gastric cancer.
Li W, Jia H, Wang J, Guan H, Li Y, Zhang D, Tang Y, Wang TD, Lu S. Li W, et al. Oncotarget. 2017 May 2;8(18):30063-30076. doi: 10.18632/oncotarget.16275. Oncotarget. 2017. PMID: 28415792 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical